BioSpace News Archive

VOTIS Subdermal Imaging Technologies, Ltd. announced that it has raised US$2.5 million in a private placement of equity to a consortium of investors in Israel, Italy, the UK, and the US.

Valeo Pharma Inc., a Canadian pharmaceutical company, announced that private payer health plans currently covering 80% of privately insured lives in Canada have agreed to provide reimbursement for Enerzair Breezhaler and Atectura Breezhaler.

Sutro Biopharma, Inc. announced that it has received a milestone payment under its collaboration and license agreement with the healthcare division of Merck KGaA, Darmstadt, Germany, related to a patient enrollment achievement in the Phase 1 dose escalation and expansion study of M1231 in adult patients with metastatic solid tumors, including non-small cell lung cancer and esophageal squamous cell carcinoma.

Unique timsTOF trueSCP revolutionizes quantitative single cell biology research with unbiased, deep single-cell 4D-Proteomics™ to complement scRNA-seq; breakthrough paper by Mann et al. identifies and quantifies >1,400 proteins in single cells

Lyra Therapeutics, Inc. announced that Maria Palasis, Ph.D., Lyra’s President and Chief Executive Officer, will participate in a fireside chat at the William Blair 41st Annual Growth Stock Conference on Thursday, June 3, 2021 at 11:30am EDT.

Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies, announced that the U.S. Food and Drug Administration is “on site” for the ROLONTIS® manufacturing facility inspection.

Learnings to be Presented by Carlos Moraes, Ph.D., from University of Miami at UMDF’s Mitochondrial Medicine Symposium on June 4, 2021

Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka Endocan Corporation. (WKN:A1W61J) (ISIN:US29271J1097) (OTC PINK:ENDO), is proud to announce it has officially received OTC Markets registration confirmations, completing its new OTC Markets registration ready to upload all newly updated State of Nevada registered corporate information.

Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, announced that Rajvir Madan has joined the company as its first Chief Digital and Information Officer.

Coya Therapeutics, Inc. (Coya™), today announced that it has appointed Ann Lee Ph.D., Senior Vice President of Cell Therapy Development and Operations at Bristol Myers Squibb (BMS), to the Company’s Board of Directors, effective immediately.